Sherwin-Williams Co (SHW)vsVersamet Royalties Corporation Common Stock (VMET)
SHW
Sherwin-Williams Co
$320.45
-1.86%
BASIC MATERIALS · Cap: $78.49B
VMET
Versamet Royalties Corporation Common Stock
$9.13
-0.98%
BASIC MATERIALS · Cap: $1.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Sherwin-Williams Co generates 32806% more annual revenue ($24.41B vs $74.18M). VMET leads profitability with a 49.9% profit margin vs 11.0%. VMET trades at a lower P/E of 26.4x. VMET earns a higher WallStSmart Score of 60/100 (C+).
SHW
Buy60
out of 100
Grade: C+
VMET
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.9%
Fair Value
$330.61
Current Price
$320.44
$10.17 discount
Intrinsic value data unavailable for VMET.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 70 in profit
Large-cap with strong market position
Generating 1.2B in free cash flow
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 58.0%
Revenue surging 391.9% year-over-year
Earnings expanding 2123.0% YoY
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Moderate valuation
Distress zone — elevated risk
Trading at 20.1x book value
Moderate valuation
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : SHW
The strongest argument for SHW centers on Return on Equity, Market Cap, Free Cash Flow.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 49.9% and operating margin at 58.0%. Revenue growth of 391.9% demonstrates continued momentum.
Bear Case : SHW
The primary concerns for SHW are PEG Ratio, P/E Ratio, Altman Z-Score. Debt-to-equity of 3.69 is elevated, increasing financial risk.
Bear Case : VMET
The primary concerns for VMET are P/E Ratio, Market Cap, Altman Z-Score.
Key Dynamics to Monitor
SHW profiles as a value stock while VMET is a growth play — different risk/reward profiles.
VMET is growing revenue faster at 391.9% — sustainability is the question.
SHW generates stronger free cash flow (1.2B), providing more financial flexibility.
Monitor SPECIALTY CHEMICALS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SHW scores higher overall (60/100 vs 60/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Sherwin-Williams Co
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.
Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is an innovative biopharmaceutical company dedicated to the development of advanced therapeutics targeting serious diseases, particularly in the areas of fungal infections and oncology, utilizing its proprietary metalloenzyme-based technology platform. With a robust and diversified clinical pipeline supported by strategic partnerships and a comprehensive intellectual property portfolio, Viamet is strategically positioned for significant growth. The company remains focused on addressing critical unmet medical needs and is committed to enhancing shareholder value through continued therapeutic advancements in its specialized areas.
Compare with Other SPECIALTY CHEMICALS Stocks
Want to dig deeper into these stocks?